Revenue and Profitability - Revenue for Q1 2022 was CNY 104,790,149.72, an increase of 38.71% compared to CNY 75,546,621.76 in the same period last year[4] - Net profit attributable to shareholders decreased by 31.82% to CNY 4,525,876.10 from CNY 6,638,128.99 year-on-year[4] - Basic earnings per share fell by 38.47% to CNY 0.0379 from CNY 0.0616 in the previous year[5] - The company reported a net profit margin improvement, with retained earnings increasing to CNY 487,215,865.26 from CNY 482,689,989.15, a slight increase of about 0.11%[32] - Net profit for the current period was ¥4,505,549.48, down from ¥5,697,004.90 in the previous period, indicating a decrease of approximately 20.9%[35] Assets and Liabilities - Total assets increased by 10.32% to CNY 1,680,056,137.69 compared to CNY 1,522,824,726.68 at the end of the previous year[5] - The company's total liabilities increased to CNY 495,553,128.82 from CNY 442,680,141.41, indicating a rise in financial obligations[31] - Current assets totaled CNY 1,238,297,579.17, up from CNY 1,079,226,690.62 at the start of the year, reflecting a growth of approximately 14.77%[30] - The total current liabilities rose to CNY 418,516,005.75 from CNY 363,298,981.24, indicating an increase of approximately 15.19%[31] Cash Flow - Cash flow from operating activities decreased by 114.76% to CNY -3,904,397.30, primarily due to increased procurement and inventory[19] - The net cash flow from operating activities was negative at -¥3,904,397.30, a decline from a positive cash flow of ¥26,458,611.96 in the previous period[39] - Cash inflow from investment activities was ¥101,082,748.33, down from ¥161,603,390.41 in the previous period, showing a decrease of about 37.5%[39] - The net cash inflow from financing activities was ¥98,881,722.01, compared to a net outflow of ¥21,405,120.37 in the previous period[40] Operating Costs and Expenses - The company reported a 71.27% increase in operating costs, attributed to both expanded revenue scale and rising raw material prices[15] - Total operating costs amounted to ¥103,433,650.54, compared to ¥75,339,636.29 in the previous period, reflecting an increase of about 37.4%[33] - The company experienced a decrease in sales expenses to ¥8,908,588.84 from ¥9,846,032.33, a reduction of about 9.5%[33] - Research and development expenses were ¥6,083,127.26, slightly down from ¥6,425,786.76 in the previous period, reflecting a decrease of about 5.3%[33] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,319[22] - The company reported a total of 32,000,000 shares held by Shanghai Dehui Group, representing a significant portion of the unrestricted shares[24] - The total number of shares held by the top 10 unrestricted shareholders amounts to 42,000,000 shares, indicating concentrated ownership[24] - The total number of shares held by the top 10 shareholders participating in margin trading is 1,085,900 shares, indicating active trading strategies[24] Future Outlook and Strategic Plans - The company plans to expand its market presence through strategic partnerships and potential acquisitions in the upcoming quarters[26] - The company is focusing on R&D for new technologies to enhance product offerings and drive future growth[26] - The company anticipates a positive outlook for the next quarter, with expectations of increased revenue driven by new product launches[26] Investment Income - Investment income surged by 2148.76%, reflecting increased returns from investments in joint ventures and associates[18] - The company reported an investment income of ¥972,725.82, a significant increase from ¥43,256.13 in the previous period[35] Share Lock-up and Issuance - The company has 375,000 shares locked for executives, with 25% eligible for release annually, reflecting a structured share release plan[25] - The company issued 663,258 new shares to Chen Peng, which will not be transferred for 6 months from the listing date[26] - The company has a total of 834,924 shares locked for JPMorgan Chase, which will also not be transferred for 6 months from the listing date[26] - The company has a total of 643,750 shares locked for Shanghai Boshin Investment, with similar transfer restrictions as other new shares[26] Financial Audits - The company did not undergo an audit for the first quarter report[41]

Financial Performance - The company's operating revenue for 2021 was ¥539,773,421.30, representing a year-over-year increase of 1.60% compared to ¥531,269,507.27 in 2020[21]. - The net profit attributable to shareholders for 2021 was ¥70,124,270.08, a decrease of 15.24% from ¥82,732,790.35 in 2020[21]. - The net profit after deducting non-recurring gains and losses was ¥26,224,621.18, down 58.52% from ¥63,217,051.08 in 2020[21]. - The net cash flow from operating activities increased significantly by 275.50% to ¥26,452,979.25 from ¥7,044,644.73 in 2020[21]. - The total assets at the end of 2021 were ¥1,522,824,726.68, an increase of 8.22% from ¥1,407,181,784.90 at the end of 2020[21]. - The net assets attributable to shareholders increased by 31.60% to ¥1,079,897,413.46 from ¥820,617,690.61 at the end of 2020[21]. - The company reported a basic earnings per share of ¥0.6305, down 20.50% from ¥0.7931 in 2020[21]. - The overall gross margin declined due to rising raw material and labor costs, as well as increased market competition[48]. - The company achieved operating revenue of 540 million yuan in 2021, a year-on-year increase of 1.6%[48]. - Net profit attributable to the parent company was 70.12 million yuan, a decrease of 15.24% compared to the previous year[48]. Research and Development - The company has established a complete R&D system for membrane materials and separation technology, promoting continuous technological innovation[38]. - The company has invested CNY 42.9352 million in R&D, accounting for 7.95% of its revenue, ensuring continuous improvement in technology and product development capabilities[44]. - Research and development expenses increased year-on-year, contributing to the decline in net profit[49]. - The company has increased its R&D personnel by 17.74%, with a total of 73 R&D staff, which now constitutes 18.91% of the workforce[65]. - The company plans to develop and optimize organic membrane materials, enhancing its position in the separation membrane industry[65]. - The company's R&D investment in 2021 amounted to ¥42,935,151.10, representing 7.95% of total revenue, an increase from 5.44% in 2020[66]. Market Position and Strategy - The company is focused on the research and application of membrane materials and membrane separation technology, which are considered key strategic materials in the new materials industry[32]. - The company has established a strong position in the domestic ceramic membrane technology sector and has developed comprehensive membrane integration technology solutions[33]. - The total production value of China's separation membrane-related industry is expected to exceed ¥360 billion in 2022, indicating significant market growth potential[33]. - The company actively participates in the lithium battery supply chain, focusing on the core processes and materials for lithium extraction from salt lake brine[39]. - The company plans to strengthen strategic cooperation and market expansion, particularly in high-growth sectors such as lithium extraction from salt lakes and clean production of iron phosphate[92]. - The company aims to enhance project delivery efficiency and operational management capabilities while ensuring quality and cost reduction[93]. Corporate Governance - The company maintains a strong governance structure, adhering to relevant laws and regulations, and ensuring the protection of shareholder interests[101]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements[102]. - The company has established independent personnel management and compensation systems, ensuring that key management personnel are not involved with the controlling shareholder[106]. - The company has a dedicated audit risk control department that reports directly to the audit committee, enhancing internal audit effectiveness[107]. - The company has established a performance evaluation system linking the income of senior management to their work performance, ensuring accountability and motivation[103]. Environmental and Social Responsibility - The company has established an environmental management system in accordance with GB/T 24001-2016/ISO 14001:2015 standards to minimize negative environmental impacts[169]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[170]. - The company actively engages in social welfare by providing scholarships to underprivileged university students, demonstrating its commitment to social responsibility[173]. - The company has implemented measures such as updating old equipment and promoting paperless operations to enhance environmental sustainability[173]. Shareholder Relations and Dividends - The company plans to distribute a cash dividend of 1.50 CNY per 10 shares, totaling 18,396,303.60 CNY for the year 2021[146]. - The cash dividend distribution represents 100% of the total profit distribution amount[146]. - The company has a clear profit distribution and cash dividend policy that complies with regulatory requirements[170]. - The company has implemented an employee stock incentive plan, with the first grant of restricted stock occurring on November 6, 2018, totaling 293,000 shares[153]. Risks and Challenges - The ongoing COVID-19 pandemic poses uncertainties that could adversely affect the company's overall performance, prompting the company to closely monitor developments and implement preventive measures[95]. - The company faces competition risks in the membrane separation industry, necessitating continuous R&D investment and market expansion efforts[93]. - The company anticipates an increase in accounts receivable due to business growth, with a focus on improving collection management and enhancing the proportion of quality customers to mitigate risks[94].

江苏久吾高科技股份有限公司 2021 年第三季度报告 证券代码：300631 证券简称：久吾高科 公告编号：2021-086 债券代码：123047 债券简称：久吾转债 江苏久吾高科技股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 1、董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法 律责任。 3、第三季度报告是否经过审计 （二）非经常性损益项目和金额 □ 是 √ 否 一、主要财务数据 （一）主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 上年同期增减 | | 营业收入（元） | 140,489,567.63 | 17.04% | 325,912,502.22 | 11.43% | | 归属于上市公司股东 | 11 ...

Financial Performance - The company's operating revenue for the reporting period was ¥185,422,934.59, representing a 7.53% increase compared to ¥172,436,700.87 in the same period last year[22]. - The net profit attributable to shareholders decreased by 57.59% to ¥8,906,046.49 from ¥21,000,729.44 year-on-year[22]. - The net profit after deducting non-recurring gains and losses was ¥3,966,971.27, down 48.89% from ¥7,761,989.66 in the previous year[22]. - The net cash flow from operating activities improved significantly to ¥5,012,085.69, a 218.97% increase from a negative cash flow of -¥4,213,060.84 in the same period last year[22]. - The total assets at the end of the reporting period were ¥1,325,705,759.37, a decrease of 5.79% from ¥1,407,181,784.90 at the end of the previous year[22]. - The company's basic earnings per share decreased by 59.36% to ¥0.0812 from ¥0.1998 year-on-year[22]. - The company's financial expenses increased by 348.20% to ¥4,322,790.76, primarily due to increased interest expenses from convertible bonds[46]. - The company's total liabilities decreased to approximately 484.20 million, down from 557.44 million at the end of the previous year[163]. Research and Development - The company focuses on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for industrial separation and environmental water treatment[29]. - R&D expenses accounted for 8.22% of the company's revenue during the reporting period, focusing on the optimization of aluminum and titanium adsorbent preparation processes[39]. - The company has established a complete R&D system for membrane materials and separation technology, promoting continuous technological advancement[32]. - The company has developed multiple core technologies in membrane separation, with most being at a leading domestic or advanced international level, which are crucial for maintaining its competitive edge[78]. - The company has taken steps to protect its core technologies through patent applications and confidentiality agreements with employees, although risks of technology leakage remain[78]. Market Position and Strategy - The company operates in various industrial sectors, including chemical, petrochemical, metallurgy, pharmaceuticals, food, and paper industries[13]. - The company has maintained a leading position in the membrane separation industry, facing competition that affects profit margins[76]. - The company is focused on expanding its market presence and enhancing R&D to maintain its competitive edge[77]. - The company aims to optimize management and reduce costs to sustain its industry leadership and performance[77]. - The company is addressing risks from downstream industry fluctuations by diversifying application fields and nurturing quality clients[77]. Corporate Governance - All directors attended the board meeting to review the report, ensuring comprehensive oversight[5]. - The financial report has been confirmed to be true, accurate, and complete by the company's management[4]. - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[5]. - The company has not reported any changes in its registered address, office address, or contact information during the reporting period[18]. - The company has not made any changes to its information disclosure practices during the reporting period[19]. Shareholder Information - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[6]. - The company has a stock incentive plan in place, with a total of 293,000 restricted shares granted to key personnel, representing 84.93% of the total incentive plan[88]. - The largest shareholder, Shanghai Dehui Group Co., Ltd., holds 29.46% of the shares, totaling 32,000,000 shares[135]. - The total number of shareholders at the end of the reporting period was 16,168[134]. - The company has maintained stable shareholder relationships, with no new strategic investors or mergers reported[136]. Fundraising and Financial Management - Total raised funds amounted to ¥24,558.17 million, with ¥98.44 million invested during the reporting period[62]. - The company has not made any changes to the use of raised funds during the reporting period[62]. - The company reported a net fundraising amount of RMB 245.58 million for the high-performance filtration membrane component and device industrialization project, with an investment completion deadline set for December 2022[65]. - The company has committed RMB 170 million in entrusted financial management, with RMB 130 million remaining outstanding[69]. - The company has not encountered any issues or other situations in the use and disclosure of fundraising[66]. Legal and Compliance - The company is involved in ongoing litigation regarding patent infringement, with claims amounting to CNY 1,331.3 million and CNY 2,019 million against various defendants[106]. - The company has initiated legal proceedings to recover overdue payments totaling CNY 75.9 million from a defendant, with the court supporting the company's claims[106]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[95]. - There were no significant asset or equity sales during the reporting period[73][74]. Risk Management - The company has detailed its risk management strategies in the report, highlighting potential operational risks[5]. - The ongoing uncertainty of the COVID-19 pandemic may adversely affect the company's overall business performance, prompting the company to closely monitor developments and implement preventive measures[79]. - The company has implemented measures to strengthen accounts receivable management, including establishing a dedicated team for collection efforts and enhancing customer credit assessments[78].

2021年04月 江苏久吾高科技股份有限公司 2021 年第一季度报告全文 证券代码：300631 江苏久吾高科技股份有限公司 2021年第一季度报告 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 第 1 页 江苏久吾高科技股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业收入（元） | 75,546,621.76 | 68,309,501.83 | 10.59% | | 归属于上市公司股东的净利润（元） | 6,638,128.99 | 7,667,214.06 | ...

Financial Performance - The company's operating revenue for 2020 was ¥531,269,507.27, representing a 7.56% increase compared to ¥493,948,395.76 in 2019[17]. - The net profit attributable to shareholders for 2020 was ¥82,732,790.35, a significant increase of 48.23% from ¥55,814,395.22 in 2019[17]. - The net profit after deducting non-recurring gains and losses was ¥63,217,051.08, up 31.94% from ¥47,913,876.35 in 2019[17]. - The company's total assets increased by 9.05% to ¥1,407,181,784.90 at the end of 2020, compared to ¥1,290,421,022.87 at the end of 2019[17]. - The basic earnings per share for 2020 was ¥0.7931, reflecting a 46.65% increase from ¥0.5408 in 2019[17]. - The company reported a net cash flow from operating activities of ¥7,044,644.73, a decrease of 88.20% from ¥59,707,863.02 in 2019[17]. - The company achieved a revenue of CNY 531.27 million in 2020, representing a year-on-year growth of 7.56%[42]. - The net profit attributable to the parent company was CNY 82.73 million, marking a significant increase of 48.23% compared to the previous year[42]. - Research and development expenses amounted to CNY 28.93 million, accounting for 5.44% of total revenue[43]. - The gross profit margin for the specialized equipment manufacturing industry was 42.54%, an increase of 1.78% compared to the previous year[49]. Dividend Policy - The company plans to distribute a cash dividend of 1.8 RMB per 10 shares to all shareholders based on a total share capital of 108,625,070 shares as of March 31, 2021[5]. - The proposed cash dividend for 2020 is 1.8 CNY per 10 shares, amounting to a total cash dividend of 19,552,512.60 CNY (including tax)[99][100]. - The cash dividend represents 23.63% of the net profit attributable to shareholders for the year 2020[101]. - The company has maintained a consistent cash dividend policy, with previous years' dividends being 1.5 CNY per 10 shares for 2018 and 2019[100][101]. - The cash dividend payout ratio for 2019 was 28.37%, and for 2018 it was 28.78%, indicating a stable dividend policy[101]. Research and Development - The company focuses on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for industrial separation and environmental water treatment[26]. - The company has established a complete R&D system for ceramic membranes and membrane separation technology, promoting continuous technological innovation[30]. - The company holds a total of 69 invention patents, 127 utility model patents, and 5 design patents, with 109 patent applications accepted[38]. - The company plans to invest 50 million in research and development to innovate new technologies over the next two years[200]. Market Position and Strategy - The company aims to become a leader in the membrane separation industry, focusing on innovation in membrane materials and technologies to support traditional industries' upgrades and contribute to energy conservation and circular economy efforts[89]. - The company will actively explore new application areas for ceramic membranes, including special water treatment and food and beverage sectors, to create new growth points[110]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[112]. - A strategic acquisition of a smaller tech firm was completed, which is anticipated to enhance the company's technological capabilities and increase market competitiveness[112]. Financial Management - The company received government subsidies amounting to ¥25,665,545.89 in 2020, compared to ¥8,613,939.80 in 2019[23]. - The company's fixed assets increased by 100.8% compared to the beginning of the period, primarily due to the completion and acceptance of IPO fundraising projects[35]. - Cash and cash equivalents decreased by 59.66% compared to the beginning of the period, mainly due to the purchase of trading financial assets and repayment of bank loans[35]. - The total cash inflow from financing activities decreased by 33.58% to 275,510,000.00 CNY, while cash outflow increased by 60.94% to 306,486,885.99 CNY, leading to a net cash flow from financing activities of -30,976,885.99 CNY[63]. Corporate Governance - The company has committed to ensuring the accuracy and completeness of its financial reports, with key personnel affirming the integrity of the annual report[4]. - The company has ensured that minority shareholders have had the opportunity to express their opinions and that their rights are adequately protected[97]. - The company has fulfilled all commitments made by its actual controllers and shareholders as of the report date[103]. - The company has a long-term commitment to comply with relevant laws and regulations regarding share transfers and repurchases[104]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements and potential operational risks in its future development outlook[5]. - The ongoing uncertainty of the COVID-19 pandemic may adversely affect the company's operations and performance, with a focus on monitoring developments and ensuring stable product and service delivery[93]. - The company is facing competition risks from both domestic and international players, which may impact profit margins; ongoing R&D investment and market expansion are essential to maintain its leading position[91]. Social Responsibility - The company actively participated in social responsibility initiatives, including donations during the COVID-19 pandemic[150]. - The company has established a scholarship fund to support outstanding students in need[150]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,078, down from 11,136 at the end of the previous month[171]. - The largest shareholder, Shanghai Dehui Group, holds 29.46% of the shares, totaling 32 million shares[171].

江苏久吾高科技股份有限公司 2020 年第三季度报告 2020 年 10 月 1 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 1,303,971,816.41 | | 1,290,421,022.87 | 1.05% | | 归属于上市公司股东的净 ...

Financial Performance - The company reported a revenue of RMB 300 million for the first half of 2020, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders was RMB 50 million, up 20% compared to the same period last year[14]. - The company has set a revenue target of RMB 600 million for the full year 2020, reflecting a growth rate of 10%[14]. - The company's operating revenue for the reporting period was ¥172,436,700.87, representing a 7.94% increase compared to ¥159,749,229.86 in the same period last year[20]. - The net profit attributable to shareholders was ¥21,000,729.44, a significant increase of 67.03% from ¥12,573,241.39 year-on-year[20]. - Operating profit reached CNY 31.46 million, up 54.51% compared to the same period last year[55]. - The gross margin for membrane integration technology solutions was 40.03%, a slight decrease of 0.23% year-on-year[66]. - The company achieved a gross profit of CNY 69,364,285.73, resulting in a gross margin of approximately 40.2%[195]. - Total comprehensive income for the period reached ¥26,656,093.44, an increase from ¥16,913,632.72 in the previous period, representing a growth of approximately 57.5%[199]. Research and Development - The company plans to invest RMB 100 million in R&D for new membrane technologies in the upcoming year[14]. - Research and development expenses amounted to 14.35 million, accounting for 8.32% of operating income, indicating a strong commitment to innovation[47]. - Research and development expenses increased significantly to CNY 14,353,241.94, up from CNY 8,256,321.60, marking a rise of 73.0%[195]. - The company has established a complete R&D system for membrane materials and separation technology, driving continuous technological innovation[35]. - The company has accumulated 66 invention patents, 97 utility model patents, and 5 design patents, with 114 patent applications accepted[47]. - The company has developed multiple core technologies in membrane separation, with most being at a leading domestic or advanced international level[100]. Market Expansion and Strategy - User data indicates a 25% increase in the number of clients utilizing the company's membrane separation technology[14]. - The company is expanding its market presence in Southeast Asia, aiming for a 30% market share by the end of 2021[14]. - The company is exploring potential acquisitions to enhance its product offerings and market reach[14]. - The company is actively expanding into new application areas, including lithium extraction from salt lake brine and industrial wastewater treatment[55]. - The company aims to enhance its overall product value through comprehensive solutions and services tailored to customer needs[30]. Financial Management - No cash dividends will be distributed to shareholders for this fiscal year[6]. - The company's cash and cash equivalents decreased by 70.48% compared to the beginning of the period, primarily due to the repayment of bank loans[43]. - The company has reduced short-term borrowings by 92.77% compared to the beginning of the period, reflecting improved financial management[43]. - The company’s debt-to-asset ratio improved to 44.48% from 45.90%, a decrease of 1.42% year-over-year[175]. - The company maintained a loan repayment rate and interest payment rate of 100%[175]. - The company reported cash and cash equivalents of approximately ¥115.33 million, down from ¥390.65 million at the end of 2019[186]. Risks and Challenges - The company has identified risks related to supply chain disruptions and is implementing strategies to mitigate these risks[5]. - The company anticipates a gradual increase in accounts receivable due to economic slowdown and increased financing costs, impacting cash flow[99]. - The company is actively monitoring the impact of the COVID-19 pandemic on its operations and is taking measures to ensure stability while exploring market opportunities[101]. Corporate Governance and Compliance - The company has fulfilled commitments related to shareholding and asset restructuring as per regulations[107]. - The company has implemented a stock repurchase plan to stabilize its stock price, which will be activated if the stock price falls below the audited net asset value for 10 consecutive trading days[108]. - The company has not faced any penalties or corrective actions during the reporting period[117]. - There are no major litigation or arbitration matters during the reporting period[113]. - The company is involved in a lawsuit regarding patent infringement with a claim amount of 998.4 million yuan[114]. Subsidiaries and Investments - The subsidiary Anhui Jiuwu Tianhong Environmental Protection Technology Co., Ltd. has a registered capital of 6,000,000 RMB and generated a net profit of 11,541,559 RMB during the reporting period[93]. - Nanjing Jiuwu Petrochemical Engineering Co., Ltd., a subsidiary, has a registered capital of 1,000,000 RMB and reported a net profit of 96,717.27 RMB[93]. - The company has a total asset value of 55,857,940 RMB for its subsidiary Anhui Jiuwu Tianhong Environmental Protection Technology Co., Ltd.[93]. - The company has a total asset value of 3,358,033.00 RMB for its subsidiary Nanjing Jiuwu Petrochemical Engineering Co., Ltd.[93]. Shareholder Information - The total number of shares increased from 105,554,000 to 105,554,000, with no new shares issued[147]. - The company distributed a cash dividend of RMB 1.5 per 10 shares to all shareholders, with no bonus shares issued[169]. - The largest shareholder, Shanghai Dehui Group Co., Ltd., holds 30.32% of the shares, totaling 32,000,000 shares[158]. - The company issued 2,540,000 convertible bonds, raising a total of 254 million yuan[153]. - The conversion price was adjusted to RMB 17.61 per share after the annual profit distribution, effective from July 10, 2020[169][170].

Dividend Policy - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 105,554,000 shares[13] - The proposed cash dividend for 2019 is CNY 1.5 per 10 shares, totaling CNY 15,833,100.00, with no stock dividends or capital reserve transfers proposed[119] - The cash dividend payout ratio for 2019 was 28.37% of the net profit attributable to shareholders[121] - The cash dividend for 2018 was also CNY 1.5 per 10 shares, with a similar payout ratio of 28.78%[120] - The cash dividend for 2017 was CNY 1.3 per 10 shares, with a payout ratio of 29.62%[120] - The company has maintained a consistent cash dividend distribution strategy over the past three years, with no stock dividends issued[120] Financial Performance - The company's operating revenue for 2019 was CNY 493,948,395.76, representing a 4.56% increase compared to CNY 472,405,817.98 in 2018[25] - The net profit attributable to shareholders for 2019 was CNY 55,814,395.22, a 1.47% increase from CNY 55,008,181.43 in 2018[25] - The net profit after deducting non-recurring gains and losses was CNY 47,913,876.35, up 5.68% from CNY 45,340,348.62 in 2018[25] - The net cash flow from operating activities decreased by 40.84% to CNY 59,707,863.02 from CNY 100,929,510.11 in 2018[25] - The total assets at the end of 2019 were CNY 1,290,421,022.87, a 38.27% increase from CNY 933,283,956.27 at the end of 2018[25] - The net assets attributable to shareholders increased by 9.96% to CNY 685,929,389.18 from CNY 623,786,053.96 at the end of 2018[25] - The basic earnings per share for 2019 was CNY 0.5408, a slight increase of 0.90% from CNY 0.5360 in 2018[25] - The diluted earnings per share for 2019 was CNY 0.5405, up 0.88% from CNY 0.5358 in 2018[25] - The weighted average return on equity for 2019 was 8.60%, down from 9.15% in 2018[25] Technology and Innovation - The company has developed multiple core technologies in membrane separation, with many at a leading domestic or advanced international level, and has implemented measures to protect these technologies[12] - The company emphasizes the importance of R&D investment to maintain its competitive edge and adapt to market changes[6] - The company has established a complete R&D system for ceramic membranes and membrane separation technology, focusing on key technology research and solution design[40] - The company has accumulated 67 invention patents, 96 utility model patents, and 5 design patents, with 108 patent applications accepted as of December 31, 2019[50] - The company has developed a waste salt resource utilization technology, demonstrating its commitment to zero discharge and deep treatment of industrial wastewater[43] - The company is focusing on the development of lithium adsorption materials and aims to prepare for large-scale production[110] - The company will continue to invest in R&D for membrane materials and technologies to meet the growing demands of downstream applications[108] Market and Sales Strategy - The company aims to enhance project signing and mitigate industry volatility risks by expanding the application fields of its solutions and improving client economic benefits[9] - The company’s revenue model is based on providing comprehensive membrane integration technology solutions, which includes design, production, and operational support[36] - The company’s sales strategy involves customized solutions based on client needs, with a focus on integrated technology solutions as the core of its marketing efforts[39] - The company actively expanded its market presence in new fields such as black and odorous water treatment and industrial wastewater "zero discharge" during the reporting period[58] - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2021[124] Financial Management and Investments - The company raised a total of RMB 192,717,000 through the public offering of 16.1 million shares at RMB 11.97 per share, with a net amount of RMB 154,190,577.66 after deducting fees[99] - The company has established a guarantee amounting to 17.31 million CNY, with details pending[168] - The company engaged in entrusted financial management, with a total amount of ¥11,000 million, including ¥5,000 million from raised funds and ¥6,000 million from self-owned funds[174] - The company has a diversified investment strategy, including bank wealth management products with varying risk levels[174] - The company reported a total of 3,000 million in structured deposits for the year 2019, with a return rate of 3.75%[176] Corporate Governance and Compliance - The company has committed to fulfilling all promises made by actual controllers, shareholders, and related parties during the reporting period[122] - The company will ensure compliance with national laws and regulations to avoid engaging in competitive business activities[127] - The company has established measures to prevent competition with its controlled enterprises, ensuring no similar business activities are conducted[127] - The company will take appropriate actions to resolve any potential conflicts of interest that may arise from competitive business activities[127] - The company has implemented changes in accounting policies in accordance with new financial instrument standards effective from January 1, 2019, which do not affect profit or loss, total assets, or net assets[145] Social Responsibility and Sustainability - The company has actively participated in social responsibility initiatives, including donations to local schools for safe drinking water[183] - The company has established a science popularization education base for middle and primary school students[184] - The company emphasizes equal development opportunities for employees through various training and career development programs[183] - Jiangsu Jiuwu High-Tech Co., Ltd. is committed to sustainability, with plans to invest 100 million yuan in green technology initiatives over the next three years[124] Risk Management - The company has established a robust framework for managing financial risks associated with its investment activities[174] - The company’s financial risk has decreased, enhancing its ability to withstand risks[199] - The company has implemented an employee stock incentive plan, approved by the board on October 7, 2018, to enhance employee motivation and retention[151]

江苏久吾高科技股份有限公司 2020 年第一季度报告全文 证券代码：300631 江苏久吾高科技股份有限公司 2020年第一季度报告 2020年04月 1 江苏久吾高科技股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业总收入（元） | 68,309,501.83 | 81,394,648.43 | -16.08% | | 归属于上市公司股东的净利润（元） | ...